Biopsy imaging and protein tests to guide IBD treatment in children
Part of Digestive system clinical trials.
This study uses advanced imaging and protein tests on tissue samples to see how well treatments work in children with inflammatory bowel disease (IBD). It aims to help doctors personalize care and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 18 or younger.
- Your child has Crohn's disease, ulcerative colitis, or is being checked for IBD.
- If your child is already on a biologic medicine (like infliximab), they can join regardless of how well it's working.
- Your child hasn't started a biologic yet — that's fine too.
- You cannot join if your child is allergic to fluorescein (a yellow dye).
- Pregnant or breastfeeding patients cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study compares two ways of looking at the colon during a routine check-up to find early signs of cancer in people with inflammatory bowel disease (IBD). One method uses a special light, and the other uses a dye. The goal is to see which is better at finding these signs.
This study looks at using precision medicine to treat inflammatory bowel disease (IBD) in people who are newly diagnosed or already being monitored. It aims to find better ways to manage the condition.
This trial is looking at children and teenagers with Crohn's disease or ulcerative colitis who are starting a biologic medicine called infliximab. It aims to learn more about how this treatment works in young patients.
This study tests a new camera system that adds texture and color enhancement to the usual white light during a colonoscopy. It aims to see if this new view helps doctors spot signs of inflammation or early cancer more clearly in people with inflammatory bowel disease.
This study looks at the typical features and risk factors in children diagnosed with inflammatory bowel disease (IBD). It may help families understand what affects IBD in kids, even if it is not testing a new treatment.
Hear when a new IBD (Inflammatory Bowel Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.